Introduction:
Lymphomas are a diverse collection of malignancies caused by the clonal growth of B-cell, T-cell, and natural killer (NK) cell subgroups of lymphocytes at various stages of development. Lymphoma is a group of diverse cancers caused by clonal lymphocyte growth. It accounts for around 5 % of cancers. Overall survival is estimated at 72 percent.
What Are Lymphomas?
Lymphomas are classified into two types: Hodgkin and non-Hodgkin lymphoma. Hodgkin lymphoma affects around 12 percent of all lymphoma patients. Because of groundbreaking research, this once-fatal diagnosis has evolved into a treatable disease. Most non-Hodgkin lymphomas are B-cell lymphomas that grow rapidly (high-grade) or slowly (low-grade). There are more than a dozen forms of B-cell non-Hodgkin lymphomas. The rest are T-cell lymphomas named after a distinct malignant white blood cell, or lymphocyte. Many lymphoma symptoms resemble those of other, less dangerous diseases. Having these signs does not indicate that one may have lymphoma. However, if one notices any changes in the body that do not go away after a few weeks, they should consult a healthcare expert. Hodgkin lymphoma and non-Hodgkin lymphoma symptoms may include:
-
Painless inflammation of one or more lymph nodes in the neck, armpits, or groin that does not go away after a few weeks.
-
Persistent fatigue occurs when one feels extremely tired daily despite receiving adequate sleep.
-
A fever that persists for longer than two days or returns to 103 degrees Fahrenheit.
-
Drenching night sweats.
-
Shortness of breath (dyspnea) occurs when the patient appears to not be getting enough air into the lungs.
-
Unexplained weight loss occurs after losing 10 percent
-
of total body weight in six months without diet or exercise.
What Are Primary Malignant Lymphomas?
Primary malignant lymphoma of the gynecologic tract is extremely rare. Most of these malignancies are non-Hodgkin lymphomas (NHL), with DLBCL (diffuse large B-cell non-Hodgkin lymphoma) being the most prevalent cell type. Most NHLs develop in lymph nodes or other lymphatic tissues, like the spleen, Waldeyer ring, or thymus. Although irregular uterine bleeding is the most common presenting symptom, additional gynecological symptoms such as vaginal discharge, pain in the pelvis, and postcoital bleeding have also been reported.
Lymphoma primarily affects the ovaries, following the cervix, uterine corpus, and vagina. Primary vulval and fallopian tube lymphoma are extremely rare. The ovary is among the most common organs affected by disseminated lymphoma. The differentiation between primary and secondary pelvic lymphoma is crucial for treatment and prognosis.
Primary illness is localized NHL originating in a gynecologic organ, while secondary disease is NHL impacting the gynecologic organs as part of a systemic disease. Diagnostic imaging is critical in determining the correct diagnosis of pelvic tumors suspected of having gynecologic lymphomas. The early detection of lymphoma prevents unnecessary surgery and allows for the rapid administration of chemotherapy or radiation therapy.
How Are Primary Gynecological Lymphomas Diagnosed, and What Are the Findings?
Primary gynecological lymphoma can be challenging to distinguish from other pelvic cancers based on clinical symptoms and imaging findings. Nonetheless, the appearance of specific imaging characteristics, particularly during an MRI (magnetic resonance imaging), can alert the radiologist to the likelihood of lymphoma.
-
Vagina and Vulva: Vaginal lymphoma is likewise extremely rare. It affects patients of all ages, with the average being in their forties. This tumor may be linked to chronic vaginitis and malakoplakia. Symptoms include vaginal soreness and discharge. Vaginal lymphoma creates solid hardening of the vaginal wall, and the tumor can extend to the rectum, bladder, or pelvis. Histologically, vaginal lymphoma is identical to lymphoma found in other gynecologic organs. Cancers originating from the vulva have a similar appearance to vaginal cancers. Vulvar lymphoma is quite rare. Patients typically present with a nodule, edema, or induration. Vulvar lymphoma can be a mass near the Bartholin gland or a clitoral lump.
-
Cervix: Primary cervical lymphoma is an uncommon disease, accounting for fewer than 1 % of all cervical cancers. Because there is no initial epithelial involvement, Pap smears cannot detect these tumors early, causing them to be rather large at first presentation. The most common symptom is intermittent vaginal bleeding or spotting. Because of early identification with frequent Pap screenings, the more prevalent squamous cervical malignancies rarely cause big masses. A thorough biopsy is required for diagnosis. Cervical lymphoma appears on CT (computed tomography) to be similar to other neoplasms, with cervical enlargement frequently observed.
-
Ovary: Primary ovarian lymphoma represents 0.5 percent of all NHL cases. Its low occurrence in the ovary has been attributed to the lack of lymphoid tissue, leading to the hypothesis that the tumor is caused by lymphocytes in the hilum or corpus luteum veins. The most typical symptom is abdominal or pelvic pain or a mass. Primary malignant lymphoma of the ovary affects people of all ages, but it most commonly occurs before menopause, with a peak prevalence in the thirties to forties. Except in regions in which Burkitt lymphoma is widespread, lymphomas account for less than 1.5 percent of all ovarian neoplasms. Burkitt lymphoma accounts for 50 percent of all ovarian cancers in children. CT scans reveal a massive, hypovascular, homogeneous ovarian tumor. The ultrasound look has also been described as nonspecific: homogenous, hypoechoic, and moderately vascular during Doppler testing.
What Is the Differential Diagnosis of Primary Gynecological Lymphomas?
When imaging reveals a large homogenous mass with retained underlying architecture, primary gynecologic lymphoma should be evaluated as a differential diagnosis for uterine, cervix, vaginal, or vulvar cancer. NHL is the most prevalent lymphoma that affects the gynecologic tract, whether primary or secondary.
Hodgkin's lymphoma is sporadic. Primary involvement is diagnosed when the gynecologic organ is the first or foremost organ to display disease, as opposed to secondary involvement, which occurs during widespread disease and is frequently detected during surgery or autopsy. Few imaging characteristics allow for a future diagnosis of primary ovarian lymphoma.
The majority of these tumors contain peritoneal implants and fluid retention, making primary ovarian lymphoma difficult to distinguish from the most frequent primary ovarian malignancy, epithelial cancer of the ovary. Primary vaginal lymphoma is often confined and has a good prognosis. Vulvar lymphoma is a fairly aggressive cancer with a low, long time disease-free survival rate.
Conclusion:
Primary malignant lymphoma is uncommon. However, a few signs can help with a future diagnosis. Unlike other gynecologic malignancies, surgical intervention is not considered a vital component of the treatment plan for gynecologic lymphomas. MRI is the best modality for seeing a hypovascular tumor while preserving anatomical planes.
